Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
Gabriele Mocciaro, Michael Allison, Benjamin Jenkins, et al.
Molecular Metabolism (2023) Vol. 73, pp. 101728-101728
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Lipid Metabolism in MASLD and MASH: from mechanism to the clinic
Fabrizia Carli, Giuseppe Della Pepa, Silvia Sabatini, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101185-101185
Open Access | Times Cited: 8
Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation
Eric D. Queathem, Zahra Moazzami, David B. Stagg, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access | Times Cited: 1
Inflammation and Oxidative Stress Induced by Obesity, Gestational Diabetes, and Preeclampsia in Pregnancy: Role of High-Density Lipoproteins as Vectors for Bioactive Compounds
Angélica Saraí Jiménez‐Osorio, Elizabeth Carreón‐Torres, Emmanuel Correa Solís, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1894-1894
Open Access | Times Cited: 13
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
Manuela Vitulo, Elisa Gnodi, Giulia Rosini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12748-12748
Open Access | Times Cited: 11
Serum bile acid and unsaturated fatty acid profiles of non-alcoholic fatty liver disease in type 2 diabetic patients
Susu Feng, Si-Jing Wang, Lin Guo, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 5, pp. 898-913
Open Access | Times Cited: 4
Oxidised Apolipoprotein Peptidome Characterises Metabolic Dysfunction‐Associated Steatotic Liver Disease
Gabriele Mocciaro, Amy L. George, Michael Allison, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Functional Aspects of Polyunsaturated Fatty Acids as Nutraceuticals
Hilal Şimşek, Aslı Uçar
(2025), pp. 211-223
Closed Access
Donepezil alleviates hepatic steatosis by mitigating ER stress via the AMPK/autophagy pathway
Wonjun Cho, Sung Woo Choi, Do Su Lim, et al.
Molecular and Cellular Endocrinology (2025), pp. 112523-112523
Closed Access
Altered Free Fatty Acids Levels and the Onset of Metabolic Syndrome in Childhood Cancer Survivors
Katarzyna Konończuk, Katarzyna Muszyńska‐Rosłan, Karolina Konstantynowicz-Nowicka, et al.
Nutrition (2025), pp. 112799-112799
Closed Access
NPR is an independent risk factor for predicting all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2007–2020
Dan Ye, Xueying Ji, Yiming Ma, et al.
Population Health Metrics (2025) Vol. 23, Iss. 1
Open Access
High-density lipoproteins and non-alcoholic fatty liver disease
Menno Hoekstra, Miranda Van Eck
Atherosclerosis Plus (2023) Vol. 53, pp. 33-41
Open Access | Times Cited: 10
Association of High-Density Lipoprotein Cholesterol with Sarcopenia in Chinese Community-Dwelling Middle-Aged and Older Adults: Evidence from 4-Year Longitudinal Study
Meng Wang, Zihan Yang, Huimin Zhai
Gerontology (2024) Vol. 70, Iss. 8, pp. 812-822
Closed Access | Times Cited: 3
Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers
Emirena Garrafa, Agnese Segala, Marika Vezzoli, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2363-2363
Open Access | Times Cited: 7
Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery
Luis V. Herrera‐Marcos, José M. Arbones-Mainar, Jesús Osada
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8285-8285
Open Access | Times Cited: 2
Dynamic changes in the mouse hepatic lipidome following warm ischemia reperfusion injury
Kim Liss, Muhammad Mousa, S. Bucha, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Trimethylamine N-oxide ameliorates hepatic damage including reduction of hepatic bile acids and cholesterol in Fxr -null mice
Masaaki Miyata, Kento Takeda, Sayuri Nagira, et al.
International Journal of Food Sciences and Nutrition (2024) Vol. 75, Iss. 4, pp. 385-395
Closed Access | Times Cited: 2
High maternal adiposity during pregnancy programs an imbalance in the lipidome and predisposes to diet-induced hepatosteatosis in the offspring
Taylor B. Scheidl, Jessica L. Wager, Larissa Baker, et al.
Bioscience Reports (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 5
Defining omics-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): In vitro studies
Swapnil C. Kamble, Payel Ghosh
Current Opinion in Biomedical Engineering (2024) Vol. 30, pp. 100534-100534
Closed Access | Times Cited: 1
Nomogram for predicting 5-year metabolic dysfunction-associated steatotic liver disease risk: retrospective cohort study
Lei Gao, Wenxia Cui, Dinghuang Mu, et al.
Endocrine Connections (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 1
Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation
Eric D. Queathem, Zahra Moazzami, David B. Stagg, et al.
(2024)
Closed Access | Times Cited: 1
Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma
Irena Frankovic, Ivana Djuričić, Ana Ninić, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 902-902
Open Access
High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study
Mengting Zhang, Dongchun Chang, Qing Guan, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access
A Mediterranean Diet-Oriented Intervention Rescues Impaired Blood Cell Bioenergetics in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Agnese Segala, Marika Vezzoli, Alice Vetturi, et al.
Diagnostics (2024) Vol. 14, Iss. 18, pp. 2041-2041
Open Access
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: NHANES 2017-2020
Zhengyu Sun, Yong Yue, Pengcheng Li
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top